bioAffinity Technologies, Inc. Finance Lease, Principal Payments
bioAffinity Technologies, Inc. (BIAF) reported Finance Lease, Principal Payments of $97.19 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:FinanceLeasePrincipalPayments · last filed 2026-08-07
- bioAffinity Technologies, Inc. finance lease, principal payments for the quarter ending 2026-06-30 was $20.02K, a 78.47% decline year-over-year.
- bioAffinity Technologies, Inc. finance lease, principal payments for the quarter ending 2026-03-31 was $77.17K, a 23.03% decline year-over-year.
- bioAffinity Technologies, Inc. finance lease, principal payments for the quarter ending 2025-12-31 was $73.07K, a 19.73% decline year-over-year.
- bioAffinity Technologies, Inc. finance lease, principal payments for the quarter ending 2025-09-30 was $58.03K, a 36.26% decline year-over-year.
- bioAffinity Technologies, Inc. finance lease, principal payments for fiscal 2025 was $324.35K, a 10.20% decline from fiscal 2024.
- bioAffinity Technologies, Inc. finance lease, principal payments for fiscal 2024 was $361.18K, a 287.38% increase from fiscal 2023.
- bioAffinity Technologies, Inc. finance lease, principal payments for fiscal 2023 was $93.24K.
| Period end | Finance Lease, Principal Payments 3 month | Finance Lease, Principal Payments 3 month as first filed | Finance Lease, Principal Payments 6 month | Finance Lease, Principal Payments 9 month | Finance Lease, Principal Payments 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $20.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $97.19K 10-Q · filed 2026-08-07 | $170.26K derived: sum of 3 quarters · filed 2026-08-07 | $228.29K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $77.17K 10-Q · filed 2026-05-11 | $150.25K derived: sum of 2 quarters · filed 2026-05-11 | $208.28K derived: sum of 3 quarters · filed 2026-05-11 | $301.25K derived: sum of 4 quarters · filed 2026-05-11 | |
| 2025-12-31 | $73.07K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $131.10K derived: sum of 2 quarters · filed 2026-03-16 | $224.08K derived: sum of 3 quarters · filed 2026-03-16 | $324.35K 10-K · filed 2026-03-16 | |
| 2025-09-30 | $58.03K 10-Q · filed 2025-11-14 | $151.01K derived: sum of 2 quarters · filed 2025-11-14 | $251.27K 10-Q · filed 2025-11-14 | $342.31K derived: sum of 4 quarters · filed 2026-05-11 | |
| 2025-06-30 | $92.97K 10-Q · filed 2025-08-14 | $193.24K 10-Q · filed 2026-08-07 | $284.28K derived: sum of 3 quarters · filed 2026-05-11 | $375.32K derived: sum of 4 quarters · filed 2026-05-11 | |
| 2025-03-31 | $100.27K 10-Q · filed 2026-05-11 | $191.30K derived: sum of 2 quarters · filed 2026-05-11 | $282.34K derived: sum of 3 quarters · filed 2026-05-11 | $372.78K derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | $91.04K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $182.08K derived: sum of 2 quarters · filed 2026-03-16 | $272.52K derived: sum of 3 quarters · filed 2026-03-16 | $361.18K 10-K · filed 2026-03-16 | |
| 2024-09-30 | $91.04K 10-Q · filed 2025-11-14 | $181.48K derived: sum of 2 quarters · filed 2025-11-14 | $270.14K 10-Q · filed 2025-11-14 | $354.95K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $90.44K 10-Q · filed 2025-08-14 | $88.67K 10-Q · filed 2024-08-14 | $179.10K 10-Q · filed 2025-08-14 | $263.91K derived: sum of 3 quarters · filed 2025-08-14 | |
| 2024-03-31 | $88.67K 10-Q · filed 2025-05-15 | $173.47K derived: sum of 2 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $84.81K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $93.24K 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $8.43K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |